For 2007, the WHO estimated 511,000 cases of multidrug-resistant (MDR)-TB, representing approximately 5% of all TB cases worldwide. Extensively drug-resistant (XDR-TB) strains have been detected in at ...

Antimicrobial Susceptibility Testing Market in North America: “North America occupied about 40% of the market share in 2020 and the region is offering significant growth opportunities for market ...

The field of antimicrobial susceptibility testing (AST) and resistance detection is rapidly evolving to address the global threat posed by antimicrobial resistance. In recent years, a ...

The global issue of antimicrobial resistance has been called a “slow motion catastrophe” resulting from the excessive and often inappropriate use of antibiotics to fight bacterial infections. 1 A long ...

The recent emergence of bacterial infections that are resistant to many existing antibiotics is driving an urgent need for tools to quickly identify the small number of therapies that are still ...

Biomarkers to predict the efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancer with actionable genetic alterations. This is an ASCO Meeting Abstract from the 2023 ASCO ...

In recent years, many efforts have been undertaken to establish new methods for DST to be used on a routine level. The epidemiology of drug-resistant and MDR-TB has posed an enormous need for faster ...